探索纤维化病理生理学在瘦和肥胖的代谢相关脂肪肝疾病:一个深入的比较
Milena Vesković1, Milka Pejović2, Nikola Šutulović3
1Institute of Pathophysiology, Faculty of Medicine, University of Belgrade, Dr Subotića 9, 11000 Belgrade, Serbia.
International journal of molecular sciences
|July 13, 2024
概括
瘦非酒精性脂肪性肝病 (NAFLD) 可以通过特定的分子途径发展为肝纤维化. 了解这些机制对于开发向疗法和早期检测瘦血性NAFLD生物标志物至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 病理生理学 病理生理学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 经常与肥胖和代谢功能障碍有关.
- 然而,瘦肉性NAFLD可以独立于代谢综合征而发展为肝纤维化,突出了不同的致病机制.
研究的目的:
- 审查和总结当前对肝纤维化机制的理解,特别是在瘦体NAFLD中.
- 在精简的NAFLD模型中识别关键的分子通路和驱动纤维化细胞过程.
主要方法:
- 关于瘦肉性NAFLD和肝纤维化现有文献的综述.
- 对瘦肉性NAFLD常用的动物模型的分析,包括氨酸/胆缺乏 (MCD) 饮食,四化碳 (CCl4) 诱导的饮食和高果糖/高胆固醇饮食.
- 检查亲纤维性分子通路和标记物的检查.
主要成果:
- 精瘦NAFLD模型中的关键的亲纤维化机制涉及到细胞外信号调节激酶 (ERK) 途径的激活.
- 高度表达α-平滑肌肉动蛋白 (α-SMA),I型原体和TGF-β是显著的贡献者.
- 巨细胞信号通路激活肝星细胞 (HSCs) 也在纤维化发育中发挥着关键作用.
结论:
- 特定的分子通路,包括ERK信号传递和HSC激活,是纤维化在瘦体NAFLD的核心.
- 现有的动物模型在完全回顾人类瘦肉NAFLD方面存在局限性;需要新的模型和比较研究.
- 对这些途径的进一步研究可以确定有针对性的疗法和生物标志物,以改善精益NAFLD的临床管理.
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
95
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
95
01:24Overview of Lipid Metabolism
1.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.3K
01:24Obesity
442
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
442
01:24Chronic Pancreatitis I: Introduction
86
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
86
01:30Liver Physiology
502
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
502